[1]
2022. Development and Validation of new UPLC method for the simultaneous estimation of darunavir, dolutegravir and ritonavir in combined tablet dosage form. Asian Journal of Pharmaceutical and Health Sciences. 12, 1 (Mar. 2022), 2624–2628. DOI:https://doi.org/10.5530/nc9nr802.